BioCryst Pharma (BCRX) Receives Additiona Funds from HHS for Peramivir Testing
Tweet Send to a Friend
On June 30, 2014, the Agreement (the “Agreement”) dated January 3, 2007 between BioCryst Pharma (Nasdaq: BCRX) and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
